Might CAR-NK –Based Immunotherapy Be More Effective, Less Toxic?

A murine study suggests this engineered combination may offer a major advantage over current CAR T-cell –based immunotherapies.

Source: CancerNetwork - July 22, 2018 Category: Cancer & Oncology Authors: John Schieszer Source Type: news